SEARCH

SEARCH BY CITATION

References

  • 1
    Khamashta MA, Asherson RA: Hughes syndrome: antiphospholipid antibodies move closer to thrombosis in 1994. Br J Rheumatol 34: 493494, 1995
  • 2
    Carreras LO, Defreyn G, Machin SJ: Arterial thrombosis, intrauterine death and “lupus” anticoagulant: detection of immunoglobulin interfering with prostacyclin formation. Lancet i: 244246, 1981
  • 3
    Carreras LO, Vermylen JG: Lupus anticoagulant and thrombosis: possible role of inhibition of prostacyclin formation. Thromb Haemost 48: 3840, 1982
  • 4
    Triplett DA: Antiphospholipid antibodies: proposed mechanisms of action. Am J Reprod Immunol 28: 211215, 1982
  • 5
    Vermylen JG, Arnout J: Is the antiphospholipid syndrome caused by antibodies directed against physiologically relevant phospholipid-protein complex? J Lab Clin Med 120: 1012, 1992
  • 6
    Meroni PL, Del Papa N, Gambini D, Tincani A, Balestrieri G: Antiphospholipid antibodies and endothelial cells. Lupus 3: 267269, 1994
  • 7
    Vismara A, Meroni PL, Tincani A, Harris EN, Barcellini W, Brucato A, Khamashta MA, Hughes GRV, Zanussi C, Balestrieri G: Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosus. Clin Exp Immunol 74: 247253, 1988
  • 8
    Hasselaar P, Derksen RHW, Blokzijl L, De Groot PG: Crossreactivity of antibodies directed against cardiolipin, DNA, endothelial cells and blood platelets. Thromb Haemost 63: 169173, 1990
  • 9
    Del Papa N, Meroni PL, Tincani A, Harris EN, Pierangeli SS, Barcellini W, Borghi MO, Balestrieri G, Zanussi C: Relationship between antiphospholipid and antiendothelial antibodies: further characterization of the reactivity on resting and cytokine-activated endothelial cells. Clin Exp Rheumatol 10: 3742, 1992
  • 10
    McGrae KR, De Michele A, Samuels P, Roth D, Kuo A, Meg QH, Rauch J, Cines DA: Detection of endothelial cell reactive immunoglobulin in patients with anti-phospholipid antibodies. Br J Haematol 79: 595605, 1991
  • 11
    Cervera R, Khamashta MA, Font J, Ramirez J, D' Cruz D, Montalban J, Lopez-Soto A, Asherson RA, Ingelmo M, Hughes GRV: Antiendothelial cell antibodies in patients with the antiphospholipid syndrome. Autoimmunity 11: 16, 1991
  • 12
    Del Papa N, Conforti G, Gambini D, La Rosa L, Tincani A, D'Cruz D, Khamashta MA, Hughes GRV: Characterization of the endothelial surface proteins recognized by anti-endothelial antibodies in primary and secondary autoimmune vasculitis. Clin Immunol Immunopathol 70: 211216, 1994
  • 13
    McNeil HP, Simpson RJ, Chesterman CN, Krilis SA: Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A 87: 41204124, 1990
  • 14
    Galli M, Comfurius P, Maasen C, Hemker HC, de Baets MH, van Breida-Vrieasman PJC, Barbui T, Beevers EM: Anticardiolipin antibodies (ACA) are directed not to cardiolipin but to a plasma protein cofactor. Lancet 335: 15441547, 1990
  • 15
    Arvieaux J, Roussel B, Jacob MC, Columb MG: Measurement of anti-phospholipid antibodies by ELISA using β2-glycoprotein I as antigen. J Immunol Methods 143: 223229, 1991
  • 16
    Viard JP, Amoura Z, Bach JF: Association of anti-β2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am J Med 93: 181186, 1992
  • 17
    Cabiedes J, Cabral AR, Segovia D Alarcon: Clinical manifestations of anti-phospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-β2glycoprotein I than with anti-phospholipid antibodies. J Rheumatol 22: 18991906, 1995
  • 18
    Balestrieri G, Tincani A, Spatola L, Allegri F, Prati E, Cattaneo R, Valesini G, Del Papa N, Meroni PL: Anti-β2 glycoprotein I antibodies: a marker of anti-phospholipid syndrome. Lupus 4: 122130, 1995
  • 19
    Martinuzzo ME, Forastiero RR, Carerras LO: Anti-β2 glycoprotein I antibodies: detection and association with thrombosis. Br J Haematol 89: 397402, 1995
  • 20
    Roubey RAS: Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulant and other “antiphospholipid” autoantibodies. Blood 84: 28542867, 1994
  • 21
    Roubey RAS, Eisenberg RA, Harper MF, Winfield JB: Anticardiolipin autoantibodies recognize β2-glycoprotein I in the absence of phospholipid. J Immunol 154: 954960, 1995
  • 22
    Ichikawa K, Khamashta MA, Koike T, Matsuura E, Hughes GRV: β2-glycoprotein I reactivity of monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome. Arthritis Rheum 37: 14531461, 1994
  • 23
    Schousboe I: β2-glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway. Blood 66: 10861091, 1985
  • 24
    Nimpf J, Bevers EM, Bomans PH: Prothrombinase activity of human platelets is inhibited by β2-glycoprotein I. Biochim Biophys Acta 884: 142149, 1986
  • 25
    Nimpf J, Wurm H, Kostner GM: β2-glycoprotein I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregation. Atherosclerosis 63: 109114, 1987
  • 26
    Vazquez-Mellado J, Llorente L, Richaud-Patin Y, Alarcon-Segovia D: Exposure of anionic phospholipids upon platelet activation permits binding of β2 glycoprotein I and through it that of IgG antiphospholipid antibodies: studies in platelets from patients with antiphospholipid syndrome and normal subjects. J Autoimmun 12: 122131, 1994
  • 27
    Del Papa N, Conforti G, Gambini D, Barcellini W, Borghi MO, Fain C, Tincani A, Balestrieri G, Tedesco F, Meroni PL: Characterisation of antiendothelial cell antibodies in antiphospholipid syndrome. In, Molecular Basis of Human Diseases. Edited by EEPolli. Amsterdam, Excerpta Medica, 1993
  • 28
    Mc Intyre JA: Immune recognition at the maternal-fetal interface: overview. Am J Reprod Immunol 28: 127131, 1992
  • 29
    La Rosa L, Meroni PL, Tincani A, Balestrieri G, Faden A, Lojacono A, Morassi L, Brocchi E, Del Papa N, Gharavi AE, Sammaritano L, Lockshin MD: β2-glycoprotein I and placental anticoagulant protein I in placentae from patients with antiphospholipid syndrome. J Rheumatol 21: 16841698, 1994
  • 30
    Del Papa N, Guidali L, Spatola L, Bonara P, Borghi MO, Tincani A, Balestrieri G, Meroni PL: Relationship between antiphospholipid and anti-endothelial antibodies. III. β2-glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules. Clin Exp Rheumatol 13: 179186, 1995
  • 31
    Simantov R, LaSala JM, Lo SK, Gharavi AE, Sammaritano LR, Salmon JE, Silverstein RL: Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J Clin Invest 96: 22112219, 1995
  • 32
    Tincani A, Meroni PL, Brucato A, Zanussi C, Allegri F, Mantelli P, Cattaneo R, Balestrieri G: Antiphospholipid and anti-mitochondrial type M5 antibodies in SLE. Clin Exp Rheumatol 3: 321326, 1985
  • 33
    Del Papa N, Guidali L, Sironi M, Shoenfeld Y, Mantovani A, Tincani A, Balestrieri G, Radice A, Sinico RA, Meroni PL: Anti-endothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion. Arthritis Rheum 39: 758766, 1996
  • 34
    Ter Borg EJ, Horst G, Hummel EJ, Limburg PC, Kallenberg CGM: Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus: a long-term, prospective study. Arthritis Rheum 33: 634643, 1990
  • 35
    Sironi M, Breviario F, Proserpio P, Biondi A, Vecchi A, van Damme J, Dejana E, Mantovani A: IL-1 stimulates IL-6 production in endothelial cells. J Immunol 142: 549553, 1989
  • 36
    Van Snick J, Cayphas S, Vink A, Uyttenhove C, Coulie M, Rubira R, Simpson RJ: Purification of NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Proc Natl Acad Sci U S A 83: 96799685, 1986
  • 37
    Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 5561, 1983
  • 38
    Pradelles P, Grassi J, Maclouf J: Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay. Anal Chem 57: 11701174, 1985
  • 39
    Carlos TM, Harlan JM: Leukocyte-endothelial adhesion molecules. Blood 84: 20682101, 1994
  • 40
    Bevers EM, Galli M: Cofactors involved in the antiphospholipid syndrome. Lupus 1: 5152, 1992
  • 41
    Matsuura E, Igarashi Y, Yasuda Y, Triplett DA, Koike T: Anti-cardiolipin antibodies recognize β2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 179: 457462, 1994
  • 42
    Matsuura E, Igarashu Y, Fujimoto M, Ichikawa K, Koike T: Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 336: 177178, 1990
  • 43
    Pengo V, Biasiolo A, Fior MG: Autoimmune phospholipid antibodies are directed against a cryptic epitope expressed when β2-glycoprotein 1 is bound to a suitable surface. Thromb Haemost 73: 2934, 1995
  • 44
    Carvalho D, Savage COS, Black CM, Pearson JD: IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. J Clin Invest 97: 111119, 1996
  • 45
    Dunky A, Neumüller J, Wagner E, Menzel J: In vitro interactions between lymphocytes and endothelial cells in psoriatic arthritis (abstract). Arthritis Rheum 38 (Suppl 9): S158, 1995
  • 46
    Arnout J: The pathogenesis of the antiphospholipid syndrome: a hypothesis based on parallelisms with heparin-induced thrombo-cytopenia. Thromb Haemost 75: 536541, 1996
  • 47
    Nawrot P, Stern D: Endothelial cell procoagulant properties and the host response. Semin Thromb Hemost 13: 391398, 1987
  • 48
    Kornberg A, Blank M, Kaufman S, Shoenfeld Y: Induction of tissue factor-like activity in monocytes by anticardiolipin antibodies. J Immunol 153: 13281331, 1994
  • 49
    Alarcon-Segovia D, Cardiel MH, Reyes E: Antiphospholipid arterial vasculopathy. J Rheumatol 16: 762767, 1989
  • 50
    Goldberger E, Elder RC, Schwartz RA, Phillips PE: Vasculitis in the antiphospholipid syndrome: a cause of ischemia responding to corticosteroids. Arthritis Rheum 35: 569572, 1992
  • 51
    Roberts WN, De Meo JH, Breitbach SA: Well-imaged large vessel vasculitis attributed to anticardiolipin antibody. Arthritis Rheum 37: 12541257, 1994
  • 52
    Lie JT: Vasculitis in the antiphospholipid syndrome: culprit or consort? J Rheumatol 21: 397399, 1994
  • 53
    Carreras LA, Maclouf J: Antiphospholipid antibodies and eicosanoids. Lupus 3: 271273, 1994
  • 54
    Lellouche F, Martinuzzo ME, Said P, Maclouf J, Carreras LA: Imbalance of thromboxane/prostacyclin biosynthesis in patients with lupus anticoagulant. Blood 78: 28942899, 1991
  • 55
    Habib A, Martinuzzo M, Lebret M, Levy-Toledano S, Carreras LO, Maclouf J: Lupus anticoagulant IgGs do not depend on serum for the induction of cyclooxygenase-2 by human endothelial cells. In, Advances in Prostaglandin, Thromboxane, and Leukotriene Research. Edited by BSamuelsson, RPaoletti, EGranstrom, PWRamwell, GFolco, SNicosia. New York, Raven Press, 1993